Paul Ginocchio
CIK 1826036 · CHIEF FINANCIAL OFFICER · last filed 2024-10-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
1
Total Filings
16
Lifetime Open-Market Net
$280.7K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Augmedix, Inc. (AUGX) Delisted | CHIEF FINANCIAL OFFICER | 135,795 | $2.35 | $319.1K | $280.7K | 10 | 2024-08-19 |
Recent Filings · Page 2 of 2
16 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-11-01 | Augmedix, Inc. (AUGX) Delisted | Buy (P) | +34,000 | $136.0K | EDGAR |
| 2021-06-09 | — | Buy (P) | +12,044 | $61.2K | |
| 2021-05-27 | — | Buy (P) | +9,356 | $42.7K | |
| 2021-05-21 | — | Buy (P) | +12,600 | $49.9K | |
| 2021-01-21 | — | Grant (A) | — | $0 | |
| 2020-10-07 | — | Grant (A) | — | $0 |
Showing 11–16 of 16
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.